SEC Form 4 · accession 0001193125-26-304739
Marex Group Ltd · MRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paolo Tonucci
Officer — See Remarks
Period of report
Jul 13, 2026
Accepted (ET)
Jul 15, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001997464
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Jul 13, 2026 | S | 11,850 | $64.2243 | D | 1,287,093 | D | |
| Ordinary SharesF3 | Jul 13, 2026 | S | 4,584 | $64.8496 | D | 1,282,509 | D | |
| Ordinary SharesF4,F5 | Jul 13, 2026 | S | 232 | $65.7301 | D | 1,282,277 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $63.645 to $64.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $64.65 to $65.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $65.715 to $65.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Remarks
Chief Strategist and CEO, Capital Markets